Sign inGet started

Morrow Phuong Khanh

Insider CIK 1928989 · LNTH Director · CRSP Chief Medical Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
LNTH Lantheus Holdings, Inc. A Award2026-05-142026-05-184,137— $07,237SEC↗
LNTH Lantheus Holdings, Inc. A Award deriv2025-05-142025-05-164,543— $04,543SEC↗
LNTH Lantheus Holdings, Inc. A Award2025-05-142025-05-162,537— $03,100SEC↗
LNTH Lantheus Holdings, Inc. A Award deriv2025-02-072025-02-111,017— $01,017SEC↗
LNTH Lantheus Holdings, Inc. A Award deriv2025-02-072025-02-121,015— $01,015SEC↗
LNTH Lantheus Holdings, Inc. A Award2025-02-072025-02-11563— $0563SEC↗
CRSP CRISPR Therapeutics AG A Award deriv2023-10-132023-10-1716,667— $016,667SEC↗
CRSP CRISPR Therapeutics AG F Tax w/h2023-05-242023-05-252,527$65.91 $166.6K4,411SEC↗
CRSP CRISPR Therapeutics AG M Exercise deriv2023-05-232023-05-256,938— $020,812SEC↗
CRSP CRISPR Therapeutics AG M Exercise2023-05-232023-05-256,938— $06,938SEC↗
CRSP CRISPR Therapeutics AG A Award deriv2023-03-102023-03-1444,620— $044,620SEC↗
CRSP CRISPR Therapeutics AG A Award deriv2023-03-102023-03-1422,000— $022,000SEC↗
CRSP CRISPR Therapeutics AG A Award deriv2022-10-072022-10-129,380— $09,380SEC↗
CRSP CRISPR Therapeutics AG A Award deriv2022-05-232022-05-2490,000— $090,000SEC↗
CRSP CRISPR Therapeutics AG A Award deriv2022-05-232022-05-2427,750— $027,750SEC↗